The trial uses two drugs.
One is a promising new cancer drug Lutetium P-S-M-A, which is injected intravenously to deliver a small amount of radioactivity to tumour cells.
The second trial drug, called Veyonda, was developed by Australian doctor Graham Kelly.
Click on the image above to listen to this feature.
